Ms. Emiko Yano is a patent attorney qualified in Japan
After graduating from the Faculty of Pharmaceutical Sciences at Kyoto University in 1984, Ms. Yano joined Yamanouchi Pharmaceutical Co., Ltd., and was involved in biopharmaceutical research and drug discovery at the Molecular Biology Research Department. From 1991, she moved to the Patent section and worked on patent prosecution, in-licensing evaluation, contract review and patent litigation especially in the biotechnology field. Ms. Yano registered as a patent attorney in 1996. From April 2011 to March 2016, she served as a group leader (Executive Director) of the First Group at the Intellectual Property Department of Astellas Pharma Co., Ltd. She joined KUBOTA from April 2017.
While working at Astellas, she was also active in external activities related to intellectual properties. From 2000 to 2011, she was a member of The First Patent Committee and Medicinal and Biotechnology Committee (where she served as Chairperson in 2010 and 2011) of The Japan Intellectual Property Association (JIPA). In 2008 and 2009, she served as a bio-pharmaceutical expert member of the "Case Study on Patentability" which was held by the Trial and Appeal Division of the Japan Patent Office.
From 2007 to 2011, Ms. Yano lectured on intellectual property at the Faculty of Pharmaceutical Sciences at the University of Tokyo. From 2012 to 2016, she was an expert member of the Intellectual Property Committee of the Japan Pharmaceutical Manufacturers Association. In 2016, she was the vice chairperson of the Intellectual Property Committee of the Pharmaceutical Manufacturers' Association of Tokyo.
From March 2014 to March 2017, she served as a member of the Patent System Subcommittee in the Industrial Structure Association of the Ministry of Economic, Trade and Industry.
She is currently the vice chairperson of the Biotechnology and Life Science Committee of the Japan Patent Attorneys Association and a Lecturer (part-time) of Tohoku University Graduate School of Medicine.
Ms. Yano speaks English and Japanese.
Antibody Pharmaceuticals and Patents (Journal of Intellectual Property Association of Japan, Vol.16, No.1, 2019)